• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.[已撤回]抵抗素升高提示预后不良并促进肺腺癌的发展。
Oncol Rep. 2023 Aug;50(2). doi: 10.3892/or.2023.8595. Epub 2023 Jun 30.
2
[Retracted] miR‑17‑5p promotes the growth of osteosarcoma in a BRCC2‑dependent mechanism.[已撤回] miR-17-5p通过一种依赖BRCC2的机制促进骨肉瘤生长。
Oncol Rep. 2024 Mar;51(3). doi: 10.3892/or.2024.8710. Epub 2024 Feb 1.
3
[Retracted] Tumor suppressor miR‑613 induces cisplatin sensitivity in non‑small cell lung cancer cells by targeting GJA1.[已撤回] 肿瘤抑制因子miR-613通过靶向GJA1诱导非小细胞肺癌细胞对顺铂的敏感性。
Mol Med Rep. 2024 Sep;30(3). doi: 10.3892/mmr.2024.13291. Epub 2024 Jul 19.
4
[Retracted] lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.[已撤回] 长链非编码RNA‑u50535通过激活CCL20/ERK信号通路促进肺癌进展。
Oncol Rep. 2024 Oct;52(4). doi: 10.3892/or.2024.8785. Epub 2024 Aug 2.
5
[Retracted] miR‑30a‑5p inhibits the proliferation, migration and invasion of melanoma cells by targeting SOX4.[已撤回] miR-30a-5p 通过靶向 SOX4 抑制黑色素瘤细胞的增殖、迁移和侵袭。
Mol Med Rep. 2023 Oct;28(4). doi: 10.3892/mmr.2023.13071. Epub 2023 Aug 18.
6
[Retracted] AdipoR1‑mediated miR‑3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway.[已撤回] 脂联素受体1介导的miR-3908通过下调与AMPK/SIRT1途径相关的STAT2抑制胶质母细胞瘤的致瘤性。
Oncol Rep. 2024 Mar;51(3). doi: 10.3892/or.2024.8697. Epub 2024 Jan 8.
7
[Retracted] Embelin-induced brain glioma cell apoptosis and cell cycle arrest via the mitochondrial pathway.[撤回] 紫铆因通过线粒体途径诱导脑胶质瘤细胞凋亡和细胞周期阻滞。
Oncol Rep. 2024 Feb;51(2). doi: 10.3892/or.2023.8691. Epub 2024 Jan 8.
8
[Retracted] LncRNA TTN‑AS1 promotes endometrial cancer by sponging miR‑376a‑3p.[已撤回]长链非编码RNA TTN-AS1通过海绵吸附miR-376a-3p促进子宫内膜癌。
Oncol Rep. 2024 Dec;52(6). doi: 10.3892/or.2024.8820. Epub 2024 Oct 11.
9
[Retracted] Isoquercitrin inhibits bladder cancer progression and by regulating the PI3K/Akt and PKC signaling pathways.[已撤回] 异槲皮苷通过调节PI3K/Akt和PKC信号通路抑制膀胱癌进展。
Oncol Rep. 2024 Feb;51(2). doi: 10.3892/or.2023.8684. Epub 2023 Dec 22.
10
[Retracted] miR‑187 inhibits the growth of cervical cancer cells by targeting FGF9.[已撤回] miR-187通过靶向FGF9抑制宫颈癌细胞的生长。
Oncol Rep. 2023 Nov;50(5). doi: 10.3892/or.2023.8632. Epub 2023 Sep 21.

引用本文的文献

1
RETRACTION: MCOLN1 Promotes Proliferation and Predicts Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma.撤回声明:MCOLN1促进胰腺导管腺癌患者的增殖并预示其预后不良。
Dis Markers. 2025 May 6;2025:9850902. doi: 10.1155/dim/9850902. eCollection 2025.

[已撤回]抵抗素升高提示预后不良并促进肺腺癌的发展。

[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.

作者信息

Zhao Cui-Cui, Chen Jing, Niu Rui-Fang, Liu Yan, Zhang Chuan-Gui

机构信息

Department of VIP Ward, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China.

Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China.

出版信息

Oncol Rep. 2023 Aug;50(2). doi: 10.3892/or.2023.8595. Epub 2023 Jun 30.

DOI:10.3892/or.2023.8595
PMID:37387445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10326819/
Abstract

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the colony formation assay data shown in Fig. 3A on p. 3399 were strikingly similar to data that were already under consideration for publication in another article written by different authors at different research institutes. Owing to the fact that the contentious data in the above article were already under consideration for publication prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 40: 3392‑3404, 2018; DOI: 10.3892/or.2018.6736].

摘要

在本文发表后,一位关注此事的读者提醒编辑注意,第3399页图3A所示的集落形成试验数据与不同研究机构的不同作者正在撰写的另一篇文章中正在考虑发表的数据惊人地相似。由于上述文章中存在争议的数据在提交给[期刊名称]之前就已经在考虑发表,编辑决定将本文从该期刊撤回。已要求作者对这些问题作出解释,但编辑部未收到令人满意的答复。编辑就由此造成的不便向读者表示歉意。[《肿瘤学报告》40: 3392 - 3404, 2018; DOI: 10.3892/or.2018.6736]